AbbVie’s biggest deal since 2019 could land soon
AbbVie (ABBV) is closing in on a deal to buy Apogee Therapeutics for $10.9 billion in cash, according to a Reuters report citing people familiar with the matter in the Financial Times. The price values Apogee at a roughly 60% premium to its closing share price on Thursday, June 18, a steep markup ...
The Source
THE STREET
Business
Discontinued Mountain Dew soda quietly returns to select stores
THE STREET·48m ago·3 min read
Business
Robert Kiyosaki makes stunning prediction on gold and silver prices
THE STREET·1h ago·3 min read
Business
Beloved spirits distillery and winery closes, no bankruptcy
THE STREET·38m ago·3 min read
Business
7-Eleven offers cheaper gas than Costco, Kroger, and Sam’s Club
THE STREET·2h ago·3 min read
Related
On this beat
Business
Discontinued Mountain Dew soda quietly returns to select stores
THE STREET·48m ago·3 min read
Business
Robert Kiyosaki makes stunning prediction on gold and silver prices
THE STREET·1h ago·3 min read
Business
Beloved spirits distillery and winery closes, no bankruptcy
THE STREET·38m ago·3 min read
Business
King Charles to be first monarch to disclose personal tax bill
FT·4h ago·3 min read